NOVO.B.DK

287.65

+2.13%↑

GMAB.DK

1,621

+0.06%↑

COLO.B.DK

380.4

+1.09%↑

HLUNB.DK

43.6

-2.64%↓

AMBUB.DK

63.05

+0.08%↑

NOVO.B.DK

287.65

+2.13%↑

GMAB.DK

1,621

+0.06%↑

COLO.B.DK

380.4

+1.09%↑

HLUNB.DK

43.6

-2.64%↓

AMBUB.DK

63.05

+0.08%↑

NOVO.B.DK

287.65

+2.13%↑

GMAB.DK

1,621

+0.06%↑

COLO.B.DK

380.4

+1.09%↑

HLUNB.DK

43.6

-2.64%↓

AMBUB.DK

63.05

+0.08%↑

NOVO.B.DK

287.65

+2.13%↑

GMAB.DK

1,621

+0.06%↑

COLO.B.DK

380.4

+1.09%↑

HLUNB.DK

43.6

-2.64%↓

AMBUB.DK

63.05

+0.08%↑

NOVO.B.DK

287.65

+2.13%↑

GMAB.DK

1,621

+0.06%↑

COLO.B.DK

380.4

+1.09%↑

HLUNB.DK

43.6

-2.64%↓

AMBUB.DK

63.05

+0.08%↑

Home・Akciju saraksts・Zealand Pharma A-S

Zealand Pharma A-S

Slēgts

295.2 0.82

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

293.2

Max

297.2

Galvenie mērījumi
By Trading Economics
Ienākumi	-15M -394M
Pārdošana	-35M 34M
P/E Sektora vidējais	2.823 49.052
EPS	-5.58
Peļņas marža	-1,158.824
Darbinieki	544
EBITDA	-26M -529M

Rekomendācijas
By TipRanks
Rekomendācijas	Neitrāls
Prognoze 12 mēnešiem	+25.15% upside

Dividendes
By Acuity
Nākamie ieņēmumi	2026. g. 13. aug.

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	-3.4B 18B
Iepriekšējā atvēršanas cena	294.38
Iepriekšējā slēgšanas cena	295.2

Zealand Pharma A-S Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 13. jūn. 23:52 UTC

China's House Price Index YoY release on June 16, 2026, faces cautious market sentiment amid ongoing declines and geopolitical tensions.

2026. g. 13. jūn. 23:51 UTC

Correlated Moves

Bitcoin has advanced since Friday, reflecting positive sentiment in the cryptocurrency market. The asset remains below its 20-day moving average and near its one-month range low.

2026. g. 13. jūn. 23:41 UTC

U.S. Stocks Surge on SpaceX IPO and Optimism Over U.S.-Iran Peace Talks, While Traders Anticipate Fed's Interest Rate Decision Amid Inflation Concerns.

2026. g. 13. jūn. 23:41 UTC

U.S. Stocks Surge on Peace Deal Optimism, Fed Expected to Hold Rates Amid Geopolitical Tensions and Key Economic Data Ahead.

2026. g. 13. jūn. 23:41 UTC

U.S. Stocks Surge on Peace Deal Optimism and Global Mineral Economy Shift Ahead of Steady Fed Rate Decision.

2026. g. 13. jūn. 23:41 UTC

U.S. Stocks Surge on SpaceX IPO and Peace Deal Hopes, While Investors Brace for Key Economic Data and Fed Rate Decision.

2026. g. 13. jūn. 23:41 UTC

Philadelphia Fed Manufacturing Index Release on June 18, 2026, Anticipates Growth Amid Mixed Economic Sentiment and Inflation Concerns.

2026. g. 13. jūn. 23:31 UTC

U.S. Industrial Production MoM data for May 2026 expected to rise by 0.2% amid cautious optimism following April's strong performance of 0.7%.

2026. g. 13. jūn. 23:21 UTC

U.S. Retail Sales MoM Report on June 17 Expected to Show Modest 0.5% Increase Amid Geopolitical Tensions and Consumer Spending Optimism

2026. g. 13. jūn. 23:21 UTC

U.S. Retail Sales Ex Autos Expected to Rise 0.5% in May Amid Cautious Consumer Sentiment and Economic Resilience

2026. g. 13. jūn. 23:21 UTC

Canada's New Housing Price Index set for June 17 release, with a forecasted slight decline amid ongoing affordability challenges and government announcements.

2026. g. 13. jūn. 23:11 UTC

Market Anticipates U.S. Building Permits Data Release Amid Cautious Optimism and Economic Concerns on June 16, 2026.

2026. g. 13. jūn. 23:02 UTC

India's RBI to release monetary policy meeting minutes amid lower-than-expected CPI inflation and rising food costs, influencing future interest rate decisions.

2026. g. 13. jūn. 23:02 UTC

Upcoming U.S. Housing Starts Data Release on June 16, 2026 Expected to Reflect Economic Conditions Amid Government Initiatives and Rising Demand.

2026. g. 13. jūn. 23:02 UTC

Investors Anticipate Further Increases in U.S. Export Prices Ahead of June 16 Release Amid Geopolitical Developments

2026. g. 13. jūn. 23:02 UTC

U.S. Housing Starts Expected to Reach 1.44 Million Units in May Amid Mixed Trends and Policy Discussions Ahead of June 16 Release

2026. g. 13. jūn. 23:02 UTC

U.S. Import Prices Report on June 16 Expected to Show 0.9% Increase Amid Geopolitical Optimism and Inflation Concerns

2026. g. 13. jūn. 23:02 UTC

Market Anticipates 1.41 Million Building Permits in May 2026 Amidst Cautious Optimism for Housing Sector Recovery.

2026. g. 13. jūn. 23:01 UTC

Macro News

DAX 30 Index rises in after-market trading amid optimism for a U.S.-Iran peace deal and President Trump's announcement on the Strait of Hormuz.

2026. g. 13. jūn. 22:51 UTC

Japan's Year-on-Year Inflation Rate Release on June 18 Expected to Show Stability Amid Mixed Economic Signals and Global Influences.

2026. g. 13. jūn. 22:51 UTC

Japan's Core Inflation Rate Expected to Hold at 1.4% Amid Cautious Market Sentiment and BOJ Policy Considerations

2026. g. 13. jūn. 22:41 UTC

Market anticipates June 15 release of NY Empire State Manufacturing Index at 13.2, signaling cautious optimism amid inflation concerns and geopolitical developments.

2026. g. 13. jūn. 22:41 UTC

Japan's Machinery Orders Expected to Rise 0.9% in April Amidst Mixed Economic Signals and Improving Investor Confidence

2026. g. 13. jūn. 22:41 UTC

Japan's Exports Expected to Rise 0.162% YoY in June Amid Positive Economic Sentiment and Geopolitical Easing, Despite Competition from China

2026. g. 13. jūn. 22:41 UTC

Mortgage Rates Set to Rise Amid Geopolitical Tensions and Economic Uncertainty, with Upcoming MBA Report Expected on June 17.

2026. g. 13. jūn. 22:32 UTC

UK Consumer Confidence Index for June 2026 Forecasted at -23 Amid Ongoing Inflation and Economic Uncertainty

2026. g. 13. jūn. 22:32 UTC

Canada's May 2026 Housing Starts Data Set for Release, Forecasted at 255K Units Amid Optimistic Market Sentiment and Government Initiatives.

2026. g. 13. jūn. 22:32 UTC

Brazil's Central Bank to Provide Key Interest Rate Insights on June 15, Amidst Cautious Market Sentiment and Global Economic Influences.

2026. g. 13. jūn. 22:32 UTC

Japan's trade deficit forecasted at -564.6 billion yen amid high import costs, but market optimism rises following easing U.S.-Iran tensions and strong Asian stock performance.

2026. g. 13. jūn. 22:32 UTC

Brazil's Retail Sales Report on June 16 Expected to Show Resilience Amid Mixed Economic Signals

Salīdzinājums

Cenas izmaiņa

Zealand Pharma A-S Prognoze

Cenas mērķis

By TipRanks

25.15% augšup

Prognoze 12 mēnešiem

Vidējais 270.582 DKK 25.15%

Augstākais 270.568 DKK

Zemākais 270.568 DKK

Pamatojoties uz 1 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Zealand Pharma A-S — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Neitrāls

1 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 1 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Zealand Pharma A-S — pēdējo 3 mēnešu laikā.

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Zealand Pharma A-S

Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark. It has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. The company offers Dasiglucagon, a single use syringe or autoinjector for the treatment of severe hypoglycemia; and Dasiglucagon bi-hormone artificial pancreas systems containing insulin and dasiglucagon. Its pipeline includes Dasiglucagon that is in Phase III clinical trials for treating congenital hyperinsulinism. The company is also developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical trials for the treatment of short bowel syndrome. The company was incorporated in 1997 and is based in Søborg, Denmark.